Suven Pharmaceuticals is all set to acquire a controlling stake in NJ Bio Inc. (NJ Bio) with an investment of $64.4 million. Based in Princeton, NJ Bio is a premier ADC/XDC-focused CRDMO offering cutting-edge solutions across the ADC value chain.
This acquisition positions the company as a key player in one of the fastest growing segments of the Pharma CDMO landscape and it also extends the company’s current ADC offering with expertise across payload chemistry, payload-linker synthesis, bioconjugation, and AD specific analytical platform. The transaction is expected to close before the end of December 2024.
Suven Pharmaceuticals is India’s leading technology-focused CDMO, offering integrated solutions in custom synthesis, process R&D, and manufacturing for global innovators.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1666.00 |
| Dr. Reddys Lab | 1225.40 |
| Cipla | 1235.00 |
| Zydus Lifesciences | 929.95 |
| Lupin | 2315.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: